Lunn, M. R., & Wang, C. H. (2008). Spinal muscular atrophy. Lancet, 371(9630), 2120–2133.

Article  PubMed  Google Scholar 

Vill, K., Schwartz, O., Blaschek, A., et al. (2021). Newborn screening for spinal muscular atrophy in Germany: Clinical results after 2 years. Orphanet Journal of Rare Diseases, 16(1), 153.

Article  PubMed  PubMed Central  Google Scholar 

Finkel, R. S., Mercuri, E., Darras, B. T., Connolly, A. M., Kuntz, N. L., Kirschner, J., et al. (2017). Nusinersen versus sham control in infantile-onset spinal muscular atrophy. New England Journal of Medicine, 377(18), 1723–1732.

Article  CAS  PubMed  Google Scholar 

Mendell, J. R., Al-Zaidy, S., Shell, R., Arnold, W. D., Rodino-Klapac, L. R., Prior, T. W., et al. (2017). Single-dose gene-replacement therapy for spinal muscular atrophy. New England Journal of Medicine, 377(18), 1713–1722.

Article  CAS  PubMed  Google Scholar 

Baranello, G., Darras, B. T., Day, J. W., Deconinck, N., Klein, A., Masson, R., et al. (2021). Risdiplam in Type 1 spinal muscular atrophy. New England Journal of Medicine, 384(10), 915–923.

Article  CAS  PubMed  Google Scholar 

Munsat, T. L., & Davies, K. E. (1992). International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscular Disorders, 2(5–6), 423–428.

Article  CAS  PubMed  Google Scholar 

Sansone, V. A., Walter, M. C., Attarian, S., Delstanche, S., Mercuri, E., Lochmüller, H., et al. (2020). Measuring outcomes in adults with spinal muscular atrophy - challenges and future directions - meeting report. Journal of Neuromuscular Diseases, 7(4), 523–534.

Article  CAS  PubMed  Google Scholar 

Mercuri, E., Finkel, R. S., Muntoni, F., Wirth, B., Montes, J., Main, M., et al. (2018). Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscular Disorders, 28(2), 103–115.

Article  PubMed  Google Scholar 

Finkel, R. S., Mercuri, E., Meyer, O. H., Simonds, A. K., Schroth, M. K., Graham, R. J., et al. (2018). Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscular Disorders, 28(3), 197–207.

Article  PubMed  Google Scholar 

Leibrock, B., Landfeldt, E., Hussong, J., Huelle, T., Mattheus, H., Thiele, S., et al. (2023). Areas of improvement in the medical care of SMA: Evidence from a nationwide patient registry in Germany. Orphanet Journal of Rare Diseases, 18(1), 32.

Article  PubMed  PubMed Central  Google Scholar 

Ravens-Sieberer, U., Erhart, M., Wille, N., Wetzel, R., Nickel, J., & Bullinger, M. (2006). Generic health-related quality-of-life assessment in children and adolescents: Methodological considerations. PharmacoEconomics, 24(12), 1199–1220.

Article  PubMed  Google Scholar 

Spieth, L. E., & Harris, C. V. (1996). Assessment of health-related quality of life in children and adolescents: An integrative review. Journal of Pediatric Psychology, 21(2), 175–193.

Article  CAS  PubMed  Google Scholar 

Landfeldt, E., Pechmann, A., McMillan, H. J., Lochmüller, H., & Sejersen, T. (2021). Costs of illness of spinal muscular atrophy: A systematic review. Applied Health Economics and Health Policy, 19(4), 501–520.

Article  PubMed  PubMed Central  Google Scholar 

Landfeldt, E., Edström, J., Sejersen, T., Tulinius, M., Lochmüller, H., & Kirschner, J. (2019). Quality of life of patients with spinal muscular atrophy: A systematic review. European Journal of Paediatric Neurology, 23(3), 347–356.

Article  PubMed  Google Scholar 

Landfeldt, E., Leibrock, B., Hussong, J., et al. (2024). Self-reported health-related quality of life of children with spinal muscular atrophy: Insights from a nationwide patient registry in Germany. Journal of Neuromuscular Diseases. 11(1), 117–128.

Article  PubMed  PubMed Central  Google Scholar 

Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20, 1727–1736.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horsman, J., Furlong, W., Feeny, D., & Torrance, G. (2003). The health utilities index (HUI): Concepts, measurement properties and applications. Health and Quality of Life Outcomes, 1, 54.

Article  PubMed  PubMed Central  Google Scholar 

Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–483.

Article  PubMed  Google Scholar 

Ludwig, K., Graf von der Schulenburg, J. M., & Greiner, W. (2018). German Value Set for the EQ-5D-5L. PharmacoEconomics, 36(6), 663–674.

Article  PubMed  PubMed Central  Google Scholar 

Feeny, D. H., Furlong, W. J., Torrance, G. W., et al. (2002). Multi-attribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care, 40, 113–128.

Article  PubMed  Google Scholar 

Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.

Article  PubMed  Google Scholar 

Uchio, Y., Kajima, K., Suzuki, H., Nakamura, K., Saito, M., & Ikai, T. (2022). Pain in spinal muscular atrophy: a questionnaire study. Physical Therapy Research, 25(3), 150–155.

Article  PubMed  PubMed Central  Google Scholar 

Yao, M., Xia, Y., Feng, Y., Ma, Y., Hong, Y., Zhang, Y., et al. (2021). Anxiety and depression in school-age patients with spinal muscular atrophy: A cross-sectional study. Orphanet Journal of Rare Diseases, 16(1), 385.

Article  PubMed  PubMed Central  Google Scholar 

Mix, L., Winter, B., Wurster, C. D., Platen, S., Witzel, S., Uzelac, Z., Graf, H., Ludolph, A. C., & Lulé, D. (2021). Quality of life in SMA patients under treatment with nusinersen. Frontiers in Neurology, 29(12), 626787.

Article  Google Scholar 

Grochtdreis, T., Dams, J., König, H. H., & Konnopka, A. (2019). Health-related quality of life measured with the EQ-5D-5L: Estimation of normative index values based on a representative German population sample and value set. The European Journal of Health Economics, 20(6), 933–944.

Article  PubMed  Google Scholar 

Henry, E. B., Barry, L. E., Hobbins, A. P., McClure, N. S., & O’Neill, C. (2020). Estimation of an instrument-defined minimally important difference in EQ-5D-5L index scores based on scoring algorithms derived using the EQ-VT version 2 valuation protocols. Value Health., 23(7), 936–944.

Article  PubMed  Google Scholar 

Eiser, C., & Morse, R. (2001). Quality-of-life measures in chronic diseases of childhood. Health Technology Assessment, 5(4), 1–157.

Article  CAS  PubMed  Google Scholar 

Pangalila, R. (2016). Quality of life in Duchenne muscular dystrophy: The disability paradox. Developmental Medicine and Child Neurology, 58(5), 435–436.

Article  PubMed  Google Scholar 

López-Bastida, J., Peña-Longobardo, L. M., Aranda-Reneo, I., Tizzano, E., Sefton, M., & Oliva-Moreno, J. (2017). Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain. Orphanet Journal of Rare Diseases, 12(1), 141.

Article  PubMed  PubMed Central  Google Scholar 

Landfeldt, E. (2023). Measuring health-related quality of life in duchenne muscular dystrophy: Current perspectives and recommendations. Journal of the Neurological Sciences, 15(446), 120545.

Article  Google Scholar 

Xu, R. H., Ma, B., Xin, H., Zhang, H., Zeng, Y., Luo, N., & Dong, D. (2023). Measurement properties of the EQ-5D-5L and PROPr in patients with spinal muscular atrophy. Health and Quality of Life Outcomes, 21(1), 123.

Article  PubMed  PubMed Central  Google Scholar 

Wohnrade, C., Velling, A. K., Mix, L., Wurster, C. D., Cordts, I., Stolte, B., et al. (2023). Health-related quality of life in spinal muscular atrophy patients and their caregivers-a prospective, cross-sectional, multi-center analysis. Brain Sciences, 13(1), 110.

Article  PubMed  PubMed Central  Google Scholar 

McMillan, H. J., Gerber, B., Cowling, T., Khuu, W., Mayer, M., Wu, J. W., et al. (2021). Burden of spinal muscular atrophy (SMA) on patients and caregivers in Canada. J Neuromuscul Dis., 8(4), 553–568.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Health Utilities Inc (HUInc). HUI Mark2 and Mark3 Reference Population Data. Available from: http://www.healthutilities.com/ (Accessed July 15, 2023).

Belter, L., Cruz, R., & Jarecki, J. (2020). Quality of life data for individuals affected by spinal muscular atrophy: A baseline dataset from the cure SMA community update survey. Orphanet Journal of Rare Diseases, 15(1), 217.

Article  PubMed  PubMed Central  Google Scholar 

Dangouloff, T., Hiligsmann, M., Deconinck, N., D’Amico, A., Seferian, A. M., Boemer, F., & Servais, L. (2023). Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screening. Developmental Medicine and Child Neurology, 65(1), 67–77.

Article  PubMed  Google Scholar 

Ellert, U., & Kurth, B. M. (2013). Health-related quality of life in adults in Germany. Bundesgesundheitsbl, 56, 643–649.

Article  CAS  Google Scholar 

van den Berg, B. (2012). Sf-6d population norms. Health Economics, 21(12), 1508–1512.